OncoCyte Corp Stock Price, News & Analysis (NYSEAMERICAN:OCX)

$4.40 -0.25 (-5.38 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$4.40
Today's Range$4.12 - $4.60
52-Week Range$3.60 - $7.95
Volume47,580 shs
Average Volume17,193 shs
Market Capitalization$130.84 million
P/E RatioN/A
Dividend YieldN/A

About OncoCyte Corp (NYSEAMERICAN:OCX)

OncoCyte Corp logoOncoCyte Corporation is a development-stage biotechnology company focused in the field of regenerative medicine. The Company is developing molecular cancer diagnostics utilizing a discovery platform that focuses on identifying genetic markers expressed in various types of cancer. It operates through the research and development of diagnostic tests for the detection of cancer segment. Its initial focus will be confirmatory diagnostics, utilizing liquid biopsy technology, for use in conjunction with imaging to confirm initial diagnoses within certain oncology indications. In addition, it will be developing screening diagnostics as replacements for screening imaging procedures. For some indications, it will also be pursuing the probability of recurrence of a specific cancer through the development of prognostics or companion diagnostics that help a physician determine which therapy is the optimal treatment for the patient. It offers diagnostic tests for lung, breast and bladder cancer.

Industry, Sector and Symbol:
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Sector: Bio Therapeutic Drugs
  • Previous Symbol: AMEX:OCX
  • CUSIP: N/A
  • Web: www.oncocyte.com
  • Trailing EPS: ($0.62)
  • Return on Equity: -211.74%
  • Return on Assets: -111.72%
  • Outstanding Shares: 31,430,000

Frequently Asked Questions for OncoCyte Corp (NYSEAMERICAN:OCX)

What is OncoCyte Corp's stock symbol?

OncoCyte Corp trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "OCX."

How were OncoCyte Corp's earnings last quarter?

OncoCyte Corp (NYSEAMERICAN:OCX) announced its quarterly earnings data on Monday, February, 27th. The biotechnology company reported ($0.11) earnings per share for the quarter, hitting the Thomson Reuters' consensus estimate of ($0.11). View OncoCyte Corp's Earnings History.

Where is OncoCyte Corp's stock going? Where will OncoCyte Corp's stock price be in 2017?

2 equities research analysts have issued 1 year target prices for OncoCyte Corp's shares. Their forecasts range from $7.75 to $7.75. On average, they expect OncoCyte Corp's share price to reach $7.75 in the next twelve months. View Analyst Ratings for OncoCyte Corp.

Who are some of OncoCyte Corp's key competitors?

Who owns OncoCyte Corp stock?

OncoCyte Corp's stock is owned by a number of of retail and institutional investors. Top institutional investors include Broadwood Capital Inc. (11.48%). View Institutional Ownership Trends for OncoCyte Corp.

Who bought OncoCyte Corp stock? Who is buying OncoCyte Corp stock?

OncoCyte Corp's stock was purchased by a variety of institutional investors in the last quarter, including Broadwood Capital Inc.. View Insider Buying and Selling for OncoCyte Corp.

How do I buy OncoCyte Corp stock?

Shares of OncoCyte Corp can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is OncoCyte Corp's stock price today?

One share of OncoCyte Corp stock can currently be purchased for approximately $4.40.

How big of a company is OncoCyte Corp?

OncoCyte Corp has a market capitalization of $130.84 million.

How can I contact OncoCyte Corp?

OncoCyte Corp's mailing address is 1010 Atlantic Ave Ste 102, ALAMEDA, CA 94501-1147, United States. The biotechnology company can be reached via phone at +1-510-7750515.

MarketBeat Community Rating for OncoCyte Corp (NYSEAMERICAN OCX)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  47 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  91
MarketBeat's community ratings are surveys of what our community members think about OncoCyte Corp and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for OncoCyte Corp (NYSEAMERICAN:OCX)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 0 Hold Ratings, 2 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $7.75

Consensus Price Target History for OncoCyte Corp (NYSEAMERICAN:OCX)

Price Target History for OncoCyte Corp (NYSEAMERICAN:OCX)

Analysts' Ratings History for OncoCyte Corp (NYSEAMERICAN:OCX)

DateFirmActionRatingPrice TargetDetails
5/23/2017Chardan CapitalBoost Price TargetBuy$6.50 -> $7.75View Rating Details
1/30/2017Canaccord GenuityReiterated RatingBuyView Rating Details
6/7/2016Benchmark Co.Boost Price TargetSpeculative Buy$7.50 -> $8.00View Rating Details
3/25/2016Lake Street CapitalInitiated CoverageBuy$8.00View Rating Details
3/15/2016Janney Montgomery ScottReiterated RatingBuy$15.00View Rating Details
(Data available from 11/18/2015 forward)


Earnings History and Estimates Chart for OncoCyte Corp (NYSEAMERICAN:OCX)

Earnings by Quarter for OncoCyte Corp (NYSEAMERICAN:OCX)

Earnings History by Quarter for OncoCyte Corp (NYSEAMERICAN OCX)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/14/2017Q2 2017($0.12)($0.13)ViewN/AView Earnings Details
2/27/2017Q4 2016($0.11)($0.11)ViewN/AView Earnings Details
3/30/2016($0.09)($0.14)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for OncoCyte Corp (NYSEAMERICAN:OCX)

No earnings estimates for this company have been tracked by MarketBeat.com


Dividend History for OncoCyte Corp (NYSEAMERICAN:OCX)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for OncoCyte Corp (NYSEAMERICAN OCX)
No insider trades for this company have been tracked by MarketBeat.com


Headline Trends for OncoCyte Corp (NYSEAMERICAN:OCX)

Latest Headlines for OncoCyte Corp (NYSEAMERICAN OCX)

Seasoned Financial Executive Joins OncoCyte as Chief Financial OfficerSeasoned Financial Executive Joins OncoCyte as Chief Financial Officer
finance.yahoo.com - November 18 at 10:08 AM
OncoCyte Corp (OCX) Lowered to Sell at Zacks Investment ResearchOncoCyte Corp (OCX) Lowered to Sell at Zacks Investment Research
www.americanbankingnews.com - November 18 at 6:06 AM
BRIEF-Oncocyte Q3 loss per share $0.22BRIEF-Oncocyte Q3 loss per share $0.22
www.reuters.com - November 15 at 7:02 AM
OncoCytes (OCX) CEO Bill Annett on Q3 2017 Results - Earnings Call TranscriptOncoCyte's (OCX) CEO Bill Annett on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - November 15 at 7:02 AM
OncoCyte Reports Third Quarter 2017 Financial ResultsOncoCyte Reports Third Quarter 2017 Financial Results
finance.yahoo.com - November 15 at 7:02 AM

Social Media

Social activity is not available for this stock.



OncoCyte Corp (NYSEAMERICAN OCX) Chart for Saturday, November, 18, 2017
Loading chart…

This page was last updated on 11/18/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.